In 2017, Peri et al. reported a favorable survival of HNSCC with NSD1 mutations accompanied by global DNA hypomethylation [53], which is also a characteristic feature of low-risk SCCs in our study. This evidence concerns the gene NSD1 and head and neck squamous cell carcinoma.